(RTTNews) - The Star Entertainment Group Limited posted a second quarter negative EBITDA of A$8 million compared to EBITDA of A$51 million, prior year. The company noted that its EBITDA results ...
Revenue declined by 11% year-over-year, while EBITDA turned negative with a -0.7% margin, compared to a robust 11.6% margin in 9M-2024. The following financial figures slide illustrates the extent of ...
We now believe DraftKings has finally gotten serious about curtailing the overspend on new player acquisition costs. Up over 80% YTD, DraftKings stock has moved from its wildly overvalued status in ...
Conifex Timber Inc. reported a challenging third quarter in 2025, with a negative EBITDA of $16.5 million, partly due to a $12 million one-time charge. The company’s stock price fell 6.82% to $0.21, ...
Quarterly Performance Highlights REC Silicon reported negative EBITDA of $7.2 million from continuing operations for Q3 2025, as the company struggles with challenging market conditions and ...
EBITDA: Negative $28 million, including a $20 million non-cash inventory impairment. Pulp Segment EBITDA: Negative $13 million. Solid Wood Segment EBITDA: Negative $9 million. NBSK Pulp Price in China ...
I've been bearish on Wayfair (NYSE:W) for a while, and it has still managed to perform worse than I expected in terms of revenue growth and improving its adjusted EBITDA margins. That being said, I am ...
The analyst expects FY23 revenues of $4.725 billion, with EPS of $(11.05) loss. While comp is trending toward less negative, the analyst still sees comp challenges in 2024. Get ahead of Wall Street ...
In line with Macao peers, Galaxy’s second quarter continued to reflect COVID-19 headwinds, with adjusted EBITDA turning to a loss of HKD 384 million, after eight consecutive quarters of above its ...
Revenue was 127% higher compared to the third quarter of fiscal 2021, which amounted to CA$3.3 million; Gross profit was a loss of CA$24.8 million, versus a gross profit loss of CA$1.1 million in the ...
(RTTNews) - Medigene AG (MDGEF.PK) reported that its first half EBITDA improved to 15.4 million euros from a negative EBITDA of 4.5 million euros, prior year, due to the partnership with BioNTech.
Despite the negative EBITDA, management maintained its full-year guidance, suggesting confidence in fourth-quarter performance. As shown in the following executive summary slide, Talgo achieved ...